These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4307140)

  • 1. Hypertension with inappropriate aldosterone stimulation.
    Christlieb AR; Hickler RB; Lauler DP; Williams GH
    N Engl J Med; 1969 Jul; 281(3):128-31. PubMed ID: 4307140
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolated hypoaldosteronism in adults. A renin-deficiency syndrome.
    Schambelan M; Stockigt JR; Biglieri EG
    N Engl J Med; 1972 Sep; 287(12):573-8. PubMed ID: 4341275
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly.
    Strauch G; Vallotton MB; Touitou Y; Bricaire H
    N Engl J Med; 1972 Oct; 287(16):795-9. PubMed ID: 4341550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary hypoaldosteronism caused by a probable anomaly of 18-hydroxylation].
    Jean R; Legrand JC; Meylan F; Rieu D; Astruc J
    Arch Fr Pediatr; 1969; 26(7):769-77. PubMed ID: 5355252
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma renin activity in panhypopituitarism. Responses to sodium restriction, furosemide and corticotrophin administration.
    Murakami M; Takeda R; Morimoto S; Hirasawa K; Uchida K
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):531-41. PubMed ID: 4111287
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin activity in congenital virilizing adrenal hyperplasia.
    Imai M; Igarashi Y; Sokabe H
    Pediatrics; 1968 May; 41(5):897-904. PubMed ID: 5654837
    [No Abstract]   [Full Text] [Related]  

  • 9. Dexamethasone-suppressible hyperaldosteronism.
    New MI; Siegal EJ; Peterson RE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppressed plasma renin activity in hypertension.
    Channick BJ; Adlin EV; Marks AD
    Arch Intern Med; 1969 Feb; 123(2):131-40. PubMed ID: 4303266
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
    Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
    Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between sweat, sodium and potassium excretion and the renin-angiotensin-aldosterone system in hypertension].
    Rosset G
    Schweiz Med Wochenschr; 1973 Mar; 103(12):439-48. PubMed ID: 4697590
    [No Abstract]   [Full Text] [Related]  

  • 13. Aldosterone production after suppression of corticotropic secretory activity.
    Spark RF; Gordon SJ; Dale SL; Melby JC
    Arch Intern Med; 1968 Nov; 122(5):394-8. PubMed ID: 4301259
    [No Abstract]   [Full Text] [Related]  

  • 14. Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease.
    Weidmann P; Reinhart R; Maxwell MH; Rowe P; Coburn JW; Massry SG
    J Clin Endocrinol Metab; 1973 May; 36(5):965-77. PubMed ID: 4349050
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-tumorous "primary" aldosteronism: II. Type not relieved by glucocorticoid.
    Salti IS; Ruse JL; Stiefel M; Delarue NC; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):11-6. PubMed ID: 5793350
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arterial hypertension and inadequate stimulation of aldosterone secretion. A new syndrome].
    Bernheim R
    Presse Med (1893); 1969 Oct; 77(42):1458. PubMed ID: 4310564
    [No Abstract]   [Full Text] [Related]  

  • 18. [The dose dependent adrenocorticotropic effect of beta-1-24-corticotropin in comparison with natural ACTH].
    Weissbecker L; Schemmel K; Leybold K
    Arztl Forsch; 1967 Oct; 21(10):385-8. PubMed ID: 4299037
    [No Abstract]   [Full Text] [Related]  

  • 19. Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia.
    New MI; Seaman MP
    J Clin Endocrinol Metab; 1970 Mar; 30(3):361-71. PubMed ID: 4312795
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of Bartter's syndrome.
    Goodman AD; Vagnucci AH; Hartroft PM
    N Engl J Med; 1969 Dec; 281(26):1435-9. PubMed ID: 4311054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.